These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
546 related articles for article (PubMed ID: 11585420)
1. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Erzen M; Rakar S; Klancnik B; Syrjänen K Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420 [TBL] [Abstract][Full Text] [Related]
2. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type. Cuff J; Longacre TA Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820 [TBL] [Abstract][Full Text] [Related]
3. Epithelial ovarian tumors in the reproductive age group: age is not an independent prognostic factor. Massi D; Susini T; Savino L; Boddi V; Amunni G; Colafranceschi M Cancer; 1996 Mar; 77(6):1131-6. PubMed ID: 8635134 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777 [TBL] [Abstract][Full Text] [Related]
5. Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis. McMeekin DS; Burger RA; Manetta A; DiSaia P; Berman ML Gynecol Oncol; 1995 Oct; 59(1):81-6. PubMed ID: 7557621 [TBL] [Abstract][Full Text] [Related]
6. Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience. Mangili G; Bergamini A; Taccagni G; Gentile C; Panina P; Viganò P; Candiani M Gynecol Oncol; 2012 Sep; 126(3):403-7. PubMed ID: 22609111 [TBL] [Abstract][Full Text] [Related]
7. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis. Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126 [TBL] [Abstract][Full Text] [Related]
8. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777 [TBL] [Abstract][Full Text] [Related]
9. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study. Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436 [TBL] [Abstract][Full Text] [Related]
10. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma. Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146 [TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors of epithelial ovarian cancer in young women]. Zhang R; Wu LY; Zhang WH; Li HJ; Li SM; Liu LY Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):264-7. PubMed ID: 12839691 [TBL] [Abstract][Full Text] [Related]
12. [Construction and utilization of the prognostic model of serous ovarian adenocarcinoma]. Yang R; Feng J; Fang XZ; Bai F; Cheng YX; Liu C; Zhu W; Li L Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):459-63. PubMed ID: 17083811 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC; Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296 [TBL] [Abstract][Full Text] [Related]
14. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation. Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441 [TBL] [Abstract][Full Text] [Related]
15. [Assessment of prognostic factors in common ovarian tumors of varying malignancy]. Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877 [TBL] [Abstract][Full Text] [Related]
16. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Gilks CB; Ionescu DN; Kalloger SE; Köbel M; Irving J; Clarke B; Santos J; Le N; Moravan V; Swenerton K; Hum Pathol; 2008 Aug; 39(8):1239-51. PubMed ID: 18602670 [TBL] [Abstract][Full Text] [Related]
17. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400 [TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas]. Shao HL; Shen DH; Xue WC; Li Y; Yu YZ Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]